Evaluation of SPP1/osteopontin expression as predictor of recurrence in tamoxifen treated breast cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluation of SPP1/osteopontin expression as predictor of recurrence in tamoxifen treated breast cancer
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-01-29
DOI
10.1038/s41598-020-58323-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Detection and localization of surgically resectable cancers with a multi-analyte blood test
- (2018) Joshua D. Cohen et al. SCIENCE
- Breast cancer risk in premalignant lesions: osteopontin splice variants indicate prognosis
- (2018) Kinga Walaszek et al. BRITISH JOURNAL OF CANCER
- Association of osteopontin with specific prognostic factors and survival in adjuvant breast cancer trials of the Hellenic Cooperative Oncology Group
- (2017) Amanda Psyrri et al. Journal of Translational Medicine
- Osteopontin at the Crossroads of Inflammation and Tumor Progression
- (2017) Luigi Mario Castello et al. MEDIATORS OF INFLAMMATION
- Osteopontin splice variants are differential predictors of breast cancer treatment responses
- (2016) Krzysztof Zduniak et al. BMC CANCER
- Prognostic Value of Osteopontin Splice Variant-c Expression in Breast Cancers: A Meta-Analysis
- (2016) Chengcheng Hao et al. Biomed Research International
- Osteopontin—A Master Regulator of Epithelial-Mesenchymal Transition
- (2016) Anai Kothari et al. Journal of Clinical Medicine
- Osteopontin promotes aromatase expression and estradiol production in human adipocytes
- (2015) Lukas Leitner et al. BREAST CANCER RESEARCH AND TREATMENT
- Tumor-Derived Osteopontin Reprograms Normal Mammary Fibroblasts to Promote Inflammation and Tumor Growth in Breast Cancer
- (2015) Y. Sharon et al. CANCER RESEARCH
- Role of osteopontin in the pathophysiology of cancer
- (2014) Lalita A. Shevde et al. MATRIX BIOLOGY
- Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis
- (2013) R Raja et al. ONCOGENE
- Biological mechanisms and clinical implications of endocrine resistance in breast cancer
- (2011) Mario Giuliano et al. BREAST
- High dietary intake of retinol leads to bone marrow hypoxia and diaphyseal endosteal mineralization in rats
- (2010) Thomas Lind et al. BONE
- Intracellular osteopontin (iOPN) and immunity
- (2010) Makoto Inoue et al. IMMUNOLOGIC RESEARCH
- Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells
- (2009) J Dai et al. ONCOGENE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now